Thema: JP3240600001
Kissei, JP3240600001
gamestop-6286878_1920.jpg - Foto: THN
Kissei stock faces Tavneos charges as approval risk escalates
Kissei stock faces extraordinary charges tied to Tavneos as Japanese regulators consider action over the drug's approval. Interim operating forecasts rose.
ad-hoc-news.de, heute 01:53 Uhr
Kissei, JP3240600001
Kissei stock: Japan questions Tavneos data reliability for ...
Japan questions Tavneos data after 23 deaths linked to liver dysfunction. For Kissei stock, results are due November 4, 2026.
ad-hoc-news.de, 23.10.26 00:39 Uhr
Kissei, JP3240600001
Kissei reports a buyback update for Kissei stock
Kissei's May 11, 2026 plan covered 1,300,000 shares. For Kissei stock, Tavneos guidance fell from JPY 12.70 billion to JPY 5.10 billion.
ad-hoc-news.de, 20.10.26 00:22 Uhr
Kissei, JP3240600001
Kissei discloses cyberattack: what it means for Kissei stock ...
Kissei disclosed exposure October 9, 2026. For Kissei stock, fiscal 2027 first-quarter net income reached JPY 4,723 million, up from JPY 2,765 million.
ad-hoc-news.de, 14.10.26 00:22 Uhr
Kissei, JP3240600001
Kissei stock reports higher quarterly profit as revenue ...
